Lakewood-Amedex Biotherapeutics Inc.
$0.25
Mkt Cap 584365
Biotech developing infection treatments for antibiotic-resistant bacteria, using a compound class that disrupts microbial membranes at the infection site.
lakewoodamedex.com ↗Summary by The Compound Family, based on the company’s own website
—
/100 Overall
Calculating score…
Running full analysis
Ready to value this company?
Run a full DCF model with Monte Carlo simulation.
Run DCF Valuation →
Run a full DCF model with Monte Carlo simulation.
Key Metrics
Loading full analysis…
Running full 6-factor analysis…